Literature DB >> 15614848

Congenital heart disease and aneuploidy.

R C Wimalasundera1, H M Gardiner.   

Abstract

Congenital heart disease (CHD) is one of the commonest prenatal diagnoses made on routine ultrasound screening. Overall, up to 33% of CHD are associated with fetal aneuploidy. However, some specific cardiac lesions have a significantly greater association with particular chromosomal abnormalities. The majority of fetuses with CHD and aneuploidy also have extra-cardiac anomalies and are best managed by a multidisciplinary team where the management and prognosis of the cardiac defect can be discussed in the context of the baby as a whole. It is therefore important for clinicians involved in the management of fetuses with CHD to be aware of the association of aneuploidy as well as the prognosis and management of these cases, so that they can appropriately counsel the parents. In this chapter, we review the frequency and types of aneuploidy associated with the commonly diagnosed CHD and discuss their management. 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15614848     DOI: 10.1002/pd.1068

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  14 in total

Review 1.  Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.

Authors:  Ray E Hershberger
Journal:  J Cardiovasc Transl Res       Date:  2008-05-20       Impact factor: 4.132

2.  Investigating 22q11.2 deletion and other chromosomal aberrations in fetuses with heart defects detected by prenatal echocardiography.

Authors:  Fernanda Teixeira da Silva Bellucco; Sintia Iole Nogueira Belangero; Leila Montenegro Silveira Farah; Maria Virgínia Lima Machado; Adriano Pastor Cruz; Lílian Maria Lopes; Marco Antonio Borges Lopes; Marcelo Zugaib; Mirlene Cecília Cernach; Maria Isabel Melaragno
Journal:  Pediatr Cardiol       Date:  2010-09-17       Impact factor: 1.655

Review 3.  Genetics and Genomics of Congenital Heart Disease.

Authors:  Samir Zaidi; Martina Brueckner
Journal:  Circ Res       Date:  2017-03-17       Impact factor: 17.367

4.  Mosaic trisomy 22 in a 4-year-old boy with congenital heart disease and general hypotrophy: A case report.

Authors:  Samira Kalayinia; Tina Shahani; Alireza Biglari; Majid Maleki; Hassan Rokni-Zadeh; Zahra Razavi; Nejat Mahdieh
Journal:  J Clin Lab Anal       Date:  2018-09-26       Impact factor: 2.352

5.  Prenatal diagnosis of nonsyndromic congenital heart defects.

Authors:  Elizabeth C Ailes; Suzanne M Gilboa; Tiffany Riehle-Colarusso; Candice Y Johnson; Charlotte A Hobbs; Adolfo Correa; Margaret A Honein
Journal:  Prenat Diagn       Date:  2013-12-17       Impact factor: 3.050

6.  Disorder of Sexual Development and Congenital Heart Defect in 47XYY: Clinical Disorder or Coincidence?

Authors:  Hanane Latrech; Imane Skikar; Mohammed El Hassan Gharbi; Abdelmjid Chraïbi; Ahmed Gaouzi
Journal:  Case Rep Endocrinol       Date:  2015-06-15

7.  The importance of copy number variation in congenital heart disease.

Authors:  Gregory Costain; Candice K Silversides; Anne S Bassett
Journal:  NPJ Genom Med       Date:  2016-09-14       Impact factor: 8.617

8.  Karyotypic and molecular genetic changes associated with fetal cardiovascular abnormalities: results of a retrospective 4-year ultrasonic diagnosis study.

Authors:  Bihui Bao; Yu Wang; Hua Hu; Hong Yao; Yuyan Li; Shuai Tang; Lihong Zheng; Yan Xu; Zhiqing Liang
Journal:  Int J Biol Sci       Date:  2013-05-09       Impact factor: 6.580

9.  Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarray.

Authors:  Robin Z Hayeems; Ny Hoang; Sebastien Chenier; Dimitri J Stavropoulos; Shuye Pu; Rosanna Weksberg; Cheryl Shuman
Journal:  Eur J Hum Genet       Date:  2014-12-10       Impact factor: 4.246

Review 10.  Genetic Evaluation and Use of Chromosome Microarray in Patients with Isolated Heart Defects: Benefits and Challenges of a New Model in Cardiovascular Care.

Authors:  Benjamin M Helm; Samantha L Freeze
Journal:  Front Cardiovasc Med       Date:  2016-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.